2nd International Conference and Exhibition on Biowaivers & Biosimilars
Date: 23 – 25 September 2013
Location: Hilton, Raleigh-North Carolina, USA
OMICS Group invites all the participants across the globe to attend the 2nd International Conference and Exhibition on Biowaivers and Biosimilars during September 23-25, 2013 Hilton, Raleigh, North Carolina, USA.
The patent expirations of generics have given a gateway to Biosimilars into the Global Pharmaceutical Economy since last few years. Though the regulatory prospects upon Follow-on Biologics were not much implemented in past years, the present circumstances of pharmaceutical R&Ds are worried about patent issues with generic drugs and their molecular entities.
The criteria required in filing of biological drugs will be discussed by popular agencies and their representatives in this meeting. Biosimilars trials and special case reports will be presented to denote the purpose and clinical data requirements for the future growth of Biosimilars and Biowaivers.
Biosimilars-2013 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biowaivers.
